“These findings suggest that changing the genetic testing paradigm to population-based testing could prevent thousands of breast and ovarian cancers," experts wrote in JAMA. 

ACR noted that Congress is returning from its August recess, with one of the “most critical” considerations pertaining to government funding for fiscal 2025. 

In a letter to Congress, the groups are urging lawmakers to support HR 9001 and lift the ban on physician-run hospitals.

The CDC estimates that just under 7% of adults in the United States continue to struggle with symptoms of long COVID.

Which modality should care teams choose for PCI guidance? While there's an argument to be made for choosing IVUS over OCT, some specialists think the two treatment options are close to equal in terms of patient outcomes. 

Digital breast tomosythesis now makes up close to 50% of mammography systems in the U.S. "Tomo is going to replace just straight digital mammography simply because of the benefit of fewer recalls," explained Debra L. Monticciolo, MD.

Due to a risk of fatal overdose, the recall is labeled as the most serious of its type. While no patients have died, two have reportedly been injured. 

The new device, already cleared by the FDA, was designed to treat femoropopliteal and below-the-knee PAD. 

While prior imaging studies have compared changes that occur in the brain before pregnancy and after childbirth, this latest analysis is the first to span multiple time points during the full gestational period.

LBBAP is a relatively new alternative to biventricular pacing. The FDA's decision was based largely on data from the BIO-CONDUCT clinical trial.